Sugar gap may reveal hidden danger in ICU patients
NCT ID NCT07240103
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at 140 critically ill ICU patients to see if the difference between glucose levels in the blood and in the fluid just under the skin (interstitial fluid) can help predict death risk and metabolic problems. Researchers measured this gap and compared it to energy use, organ function, and survival. The goal is to find a simpler, less invasive way to monitor metabolism in very sick patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could give doctors a simple, minimally invasive way to monitor metabolism and predict outcomes in ICU patients.
- What could go wrong
- This is a small, completed observational study, not a treatment trial. The findings may not apply to all ICU patients or lead to changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, 210000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI may predict transfusion needs to shield ICU patients from organ failure
- A simple blood test trend may flag ICU patients at risk
- Could a simple CT scan reveal which ICU cancer patients are at highest risk?
- A gentle touch from family may calm the ICU storm
- Can remote exercise rebuild strength in kids after ICU?
- Fasting in the ICU: a metabolic key to immune response?